Kinin Receptor Agonism Restores Hindlimb Postischemic Neovascularization Capacity in Diabetic Mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.114.219196PMID 25398240
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinin receptors in vascular biology and pathology.

  2014cited by this paper
• Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes

  2013influential reference
• Further pharmacological evaluation of a novel synthetic peptide bradykinin B2 receptor agonist

  2013cited by this paper
• Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

  2012cited by this paper
• Kinins as therapeutic agents in cardiovascular and renal diseases.

  2011cited by this paper
• Recombinant Human Interleukin-11 Treatment Enhances Collateral Vessel Growth After Femoral Artery Ligation

  2011cited by this paper
• Tissue Kallikrein Is Essential for Invasive Capacity of Circulating Proangiogenic Cells

  2011cited by this paper
• Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus

  2011cited by this paper
• Arteriogenesis Is Modulated By Bradykinin Receptor Signaling

  2011cited by this paper
• Dysregulated Selectin Expression and Monocyte Recruitment During Ischemia-Related Vascular Remodeling in Diabetes Mellitus

  2011cited by this paper
• Regulation of Bone Marrow-Derived Vascular Progenitor Cell Mobilization and Maintenance

  2010cited by this paper
• Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance.

  2010cited by this paper
• Incidence of Lower-Limb Amputation in the Diabetic and Nondiabetic General Population

  2009cited by this paper
• VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus.

  2009cited by this paper
• Diabetes Mellitus Activates Signal Transduction Pathways Resulting in Vascular Endothelial Growth Factor Resistance of Human Monocytes

  2009cited by this paper
• Novel kinin B1 receptor agonists with improved pharmacological profiles.

  2009influential reference
• Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptor.

  2009influential reference
• Kallikrein protects against microalbuminuria in experimental type I diabetes.

  2009influential reference
• Integrative Physiology/Experimental Medicine Critical Role of Tissue Kallikrein in Vessel Formation and Maturation Implications for Therapeutic Revascularization

  2009influential reference
• Role of Bradykinin, Nitric Oxide, and Angiotensin II Type 2 Receptor in Imidapril-Induced Angiogenesis

  2008influential reference
• Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia

  2008cited by this paper
• Role of Kinin B2 Receptor Signaling in the Recruitment of Circulating Progenitor Cells With Neovascularization Potential

  2008cited by this paper
• A Novel Inflammatory Pathway Involved in Leukocyte Recruitment: Role for the Kinin B1 Receptor and the Chemokine CXCL51

  2007cited by this paper
• Tetrapeptide AcSDKP Induces Postischemic Neovascularization Through Monocyte Chemoattractant Protein-1 Signaling

  2006influential reference
• Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A.

  2005influential reference
• CD8+ T Lymphocytes Regulate the Arteriogenic Response to Ischemia by Infiltrating the Site of Collateral Vessel Development and Recruiting CD4+ Mononuclear Cells Through the Expression of Interleukin-16

  2005cited by this paper
• Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb.

  2005cited by this paper
• Impairment in Postischemic Neovascularization in Mice Lacking the CXC Chemokine Receptor 3

  2005influential reference
• Prophylactic gene therapy with human tissue kallikrein ameliorates limb ischemia recovery in type 1 diabetic mice.

  2004cited by this paper
• Dual Effect of Angiotensin-Converting Enzyme Inhibition on Angiogenesis in Type 1 Diabetic Mice

  2004cited by this paper
• Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment.

  2004influential reference
• Vascular Endothelial Growth Factor‐B Promotes In Vivo Angiogenesis

  2003cited by this paper
• Impaired Arteriogenic Response to Acute Hindlimb Ischemia in CD4-Knockout Mice

  2003cited by this paper
• Interleukin-18/Interleukin-18 Binding Protein Signaling Modulates Ischemia-Induced Neovascularization in Mice Hindlimb

  2002influential reference
• Angiotensin II Angiogenic Effect In Vivo Involves Vascular Endothelial Growth Factor- and Inflammation-Related Pathways

  2002cited by this paper
• Targeting Kinin B1 Receptor for Therapeutic Neovascularization

  2002cited by this paper
• Reversal of Angiogenic Growth Factor Upregulation by Revascularization of Lower Limb Ischemia

  2002cited by this paper
• Renin-angiotensin and kallikrein-kinin systems coordinately modulate angiogenesis.

  2002cited by this paper
• Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures

  2002cited by this paper
• Blood monocyte concentration is critical for enhancement of collateral artery growth.

  2002cited by this paper
• Rescue of Impaired Angiogenesis in Spontaneously Hypertensive Rats by Intramuscular Human Tissue Kallikrein Gene Transfer

  2001cited by this paper
• Proangiogenic Effect of Angiotensin-Converting Enzyme Inhibition Is Mediated by the Bradykinin B2 Receptor Pathway

  2001influential reference
• Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Local Delivery of Human Tissue Kallikrein Gene Accelerates Spontaneous Angiogenesis in Mouse Model of Hindlimb Ischemia

  2001cited by this paper
• Decreased Flow-Dependent Dilation in Carotid Arteries of Tissue Kallikrein-Knockout Mice

  2001cited by this paper
• Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.

  2000cited by this paper
• Antiangiogenic Effect of Interleukin-10 in Ischemia-Induced Angiogenesis in Mice Hindlimb

  2000cited by this paper
• Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals.

  2000influential reference
• Bradykinin Stimulates Tissue Plasminogen Activator Release From Human Forearm Vasculature Through B2 Receptor–Dependent, NO Synthase–Independent, and Cyclooxygenase-Independent Pathway

  2000cited by this paper
• Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

  1999cited by this paper
• Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.

  1998cited by this paper
• Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion.

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion.

  1997cited by this paper
• Involvement of bradykinin B1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 beta in vivo in the mouse.

  1996cited by this paper
• Endothelium‐derived relaxing and contracting factors

  1991cited by this paper
• Endothelium‐derived relaxing and contracting factors

  1989cited by this paper

• Kallikrein–kinin system as a potential target for the treatment of intervertebral disc degeneration

  2025cites this paper
• Sex-specific regulation of prolactin secretion by pituitary bradykinin receptors.

  2022cites this paper
• Topical estrogen application promotes cutaneous wound healing in db/db female mice with type 2 diabetes

  2022cites this paper
• Healing of diabetic foot ulcers is independently associated with the use of angiotensin receptor blockers but not with those of diuretics and angiotensin conversion enzyme inhibitors.

  2022cites this paper
• Kinins and Kinin Receptors in Cardiovascular and Renal Diseases

  2021influential citation
• Association Between the ACE Insertion/Deletion Polymorphism and Risk of Lower-Limb Amputation in Patients With Long-Standing Type 1 Diabetes.

  2021cites this paper
• Kinins and Their Receptors as Potential Therapeutic Targets in Retinal Pathologies

  2021cites this paper
• Role of Matricellular CCN Proteins in Skeletal Muscle: Focus on CCN2/CTGF and Its Regulation by Vasoactive Peptides

  2021cites this paper
• Pharmacological Modulation of Blood–Brain Barrier Permeability by Kinin Analogs in Normal and Pathologic Conditions

  2020cites this paper
• Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication

  2019cites this paper
• Bradykinin contributes to immune liver injury via B2R receptor-mediated pathways in trichloroethylene sensitized mice: A role in Kupffer cell activation.

  2019cites this paper
• Role of Toll-like receptor 4 in critical limb ischaemia

  2018cites this paper
• Kinin B1 receptors as a therapeutic target for inflammation

  2018cites this paper
• Pulmonary vascular dysfunction in metabolic syndrome

  2018cites this paper
• Kinin receptors: Key regulators of autoimmunity.

  2017cites this paper
• Neuroprotective effect of kinin B1 receptor activation in acute cerebral ischemia in diabetic mice

  2017cites this paper
• Safety and pharmacokinetics of a kinin B1 receptor peptide agonist produced with different counter-ions

  2016cites this paper
• Kallikrein(K1)-kinin-kininase (ACE) and end-organ damage in ischemia and diabetes: therapeutic implications

  2016cites this paper
• Improvement of skin wound healing in diabetic mice by kinin B2 receptor blockade.

  2016cites this paper
• Système kallicréine-kinines et diabète

  2015cites this paper
• Rôle du système kallicréine-kinine(s) dans les complications du diabète

  2015cites this paper
• Critical insights into the beneficial and protective actions of the kallikrein-kinin system.

  2015cites this paper